key: cord-0955075-65syefv7 authors: Chatzimichail, Theodora; Hatjimihail, Aristides T. title: A Software Tool for Calculating the Uncertainty of Diagnostic Accuracy Measures date: 2021-02-27 journal: Diagnostics (Basel) DOI: 10.3390/diagnostics11030406 sha: d620a106b8a75d4387cde823138228b91d94a9e9 doc_id: 955075 cord_uid: 65syefv7 Screening and diagnostic tests are applied for the classification of people into diseased and non-diseased populations. Although diagnostic accuracy measures are used to evaluate the correctness of classification in clinical research and practice, there has been limited research on their uncertainty. The objective for this work was to develop a tool for calculating the uncertainty of diagnostic accuracy measures, as diagnostic accuracy is fundamental to clinical decision-making. For this reason, the freely available interactive program Diagnostic Uncertainty has been developed in the Wolfram Language. The program provides six modules with nine submodules for calculating and plotting the standard combined, measurement and sampling uncertainty and the resultant confidence intervals of various diagnostic accuracy measures of screening or diagnostic tests, which measure a normally distributed measurand, applied at a single point in time to samples of non-diseased and diseased populations. This is done for differing sample sizes, mean and standard deviation of the measurand, diagnostic threshold and standard measurement uncertainty of the test. The application of the program is demonstrated with an illustrative example of glucose measurements in samples of diabetic and non-diabetic populations, that shows the calculation of the uncertainty of diagnostic accuracy measures. The presented interactive program is user-friendly and can be used as a flexible educational and research tool in medical decision-making, to calculate and explore the uncertainty of diagnostic accuracy measures. Diagnosis in medicine is the determination of the nature of a disease condition [1] . The term diagnosis is derived from the Greek word "διάγνωσις" meaning "discernment". It is assumed that there is a dichotomy between the populations with and without a disease condition. Diagnostic tests or procedures are applied for the classification of people into the respective disjoint groups. The probability distributions of the measurand of a quantitative diagnostic test in each of the diseased and non-diseased populations are overlapping. The results of a test though can be dichotomized, by assigning a diagnostic threshold or cutoff point ( Figure 1 ) [1] . The possible test results are summarized in Table 1 . It is assumed that there is a reference ("gold standard") diagnostic method correctly classifying a subject as diseased or non-diseased [2] . The ratio of the diseased to the total population (diseased and non-diseased) at a single point in time is the prevalence rate (r) of the disease. There is a persistent need of estimating the uncertainty of diagnostic accuracy measures, especially regarding screening and diagnostic tests of life-threatening diseases. The current pandemic of novel corona virus disease 2019 (COVID-19) has exposed this unequivocally [3] [4] [5] [6] [7] . There has been extensive research on either diagnostic accuracy or uncertainty, however, extremely limited research has been done on both subjects [8] [9] [10] [11] . The program Diagnostic Uncertainty has been developed to explore the combined, measurement and sampling uncertainty of diagnostic accuracy measures as: Diagnostic accuracy is fundamental to clinical decision-making [12] , 2. Defining the permissible measurement uncertainty is critical to quality and risk management in laboratory medicine [13] . 3 . Sampling uncertainty is decisive for clinical study design to evaluate a screening or diagnostic test [14] . This program Diagnostic Uncertainty has been developed to explore the combined, measurement and sampling uncertainty of diagnostic accuracy measures as: 1. Diagnostic accuracy is fundamental to clinical decision-making [12] , 2. Defining the permissible measurement uncertainty is critical to quality and risk management in laboratory medicine [13] . Sampling uncertainty is decisive for clinical study design to evaluate a screening or diagnostic test [14] . There are diagnostic accuracy measures (DAM) used for evaluating the discriminative ability of the test in clinical research and practice [2] . These are [15] : Error-based measures, estimating misclassification rates. These include sensitivity (Se), specificity (Sp), overall diagnostic accuracy (ODA), Youden's index (J), Euclidean distance (ED) and concordance probability (CZ). Information-based measures, assisting the interpretation of each single test result. These include positive predictive value (PPV), negative predictive value (NPV), likelihood ratio for positive result (LR+) and likelihood ratio for negative result (LR-). Association-based measures, estimating the strength of the association between the test results and the reference diagnostic method. These include diagnostic odds ratio (DOR). They can be further classified as following: 1. Defined conditionally on There are diagnostic accuracy measures (DAM) used for evaluating the discriminative ability of a screening or diagnostic test in clinical research and practice [2] . These are [15] : Error-based measures, estimating misclassification rates. These include sensitivity (Se), specificity (Sp), overall diagnostic accuracy (ODA), Youden's index (J), Euclidean distance (ED) and concordance probability (CZ). Information-based measures, assisting the interpretation of each single test result. These include positive predictive value (PPV), negative predictive value (NPV), likelihood ratio for positive result (LR+) and likelihood ratio for negative result (LR−). Association-based measures, estimating the strength of the association between the test results and the reference diagnostic method. These include diagnostic odds ratio (DOR). They can be further classified as following: 1. Defined conditionally on The test outcome: positive predictive value and negative predictive value. As prevalence a. Invariant: sensitivity, specificity, diagnostic odds ratio, likelihood ratio for positive result, likelihood ratio for negative result, Youden's index, Euclidean distance and concordance probability. b. Dependent: positive predictive value, negative predictive value and overall diagnostic accuracy. The natural frequency and the probability definitions of the above diagnostic accuracy measures are presented in Table 2 . The symbols are explained in Appendix A. The symbols are explained in Appendix A. Uncertainty is an expression of imperfect or deficient information. When quantifiable it can be represented with probability [16] . The following components of the combined uncertainty of the diagnostic accuracy measures will be considered: As measurements are inherently variable, measurement uncertainty is defined as a "parameter, associated with the result of a measurement, that characterizes the dispersion of the values that could reasonably be attributed to the measurand" [17] . Measurement uncertainty is replacing the total analytical error concept [18] . Diagnostic accuracy measures are estimated by applying a screening or diagnostic test to samples of populations. Sampling heterogeneity contributes to the combined uncertainty of the diagnostic accuracy measures [19] . Even when simple random sampling is applied, there is inherent sample heterogeneity [20] . A sample of size n is considered as simple random sample, if all possible samples of the same size are equally probable [21] . For the calculation of the uncertainty of the diagnostic accuracy measures of a screening or diagnostic test based on a measurand, it is assumed that: There is a reference ("gold standard") diagnostic method classifying correctly a subject as diseased or non-diseased [22] . Either the values of the measurand or their transforms [23, 24] are normally distributed in each of the diseased and non-diseased populations. Measurement uncertainty is normally distributed and homoscedastic in the diagnostic threshold's range. The sampling is simple random. If the measurement is above the threshold the patient is classified as test-positive, otherwise as test-negative. The calculation of the diagnostic accuracy measures is based on their probability definitions ( Table 2 ). The sensitivity and specificity can be defined in terms of the error function and the complementary error function (see Appendix B). The other diagnostic accuracy measures can be expressed in terms of sensitivity, specificity and prevalence rate and calculated as shown in Appendix B. The uncertainty of an input parameter or a diagnostic accuracy measure x can be expressed in the forms of standard and expanded uncertainty. The former, denoted as u(x) equals the standard deviation of x. The later, denoted as U(x), is defined as an interval around x including x with probability p [25] . The standard measurement uncertainty u m of a measurand is estimated from a sample of n u measurements, as described in "Guide to the expression of uncertainty in measurement"(GUM) and "Expression of measurement uncertainty in laboratory medicine" [17] . Bias may be considered as a component of the standard measurement uncertainty [26] . If m P and s P the mean and standard deviation of a measurand in a population sample of size n P , then the standard sampling standard uncertainties of m P and s P are: If u m the standard measurement uncertainty of a screening or diagnostic test measuring a measurand and m P and s P the mean and standard deviation of the measurand in a population sample of size n P , then the standard combined uncertainties of the mean m P and standard deviation s P are: Sampling Uncertainty of Prevalence Rate If n D and n D the respective numbers of non-diseased and diseased in a population sample, then the standard uncertainty of the prevalence rate r = n D n D +n D of the disease can be approximated as: according to the Agresti-Coull adjustment of the Waldo interval [27] . The standard combined uncertainty u c (x) of each diagnostic accuracy measure x is calculated by applying the rules of uncertainty propagation from the input values to the calculated diagnostic accuracy measure (see Appendix B), according to GUM [28, 29] , with a first-order Taylor series approximation to uncertainty propagation [30] . When there are l components of uncertainty, with standard uncertainties u i (x) respectively, then: Expanded Uncertainty of Diagnostic Accuracy Measures The effective degrees of freedom v e f f of the standard combined uncertainty u c (x) are calculated using the Welch-Satterthwaite formula [31, 32] : If v min the minimum of the respective degrees of freedom v 1 , v 2 , . . . , v l then: If F v (z) the cumulative distribution function of the Student's t-distribution with v degrees of freedom and u c (x) the standard combined uncertainty of a diagnostic accuracy measure x, its expanded combined uncertainty, at a confidence level p, is calculated as: The resultant confidence interval (CI) of x, at the same confidence level p, is: To calculate the uncertainty of the diagnostic accuracy measures, the interactive program Diagnostic Uncertainty was developed in the Wolfram Language [33] , using Wolfram Mathematica ® Ver. 12.2, Wolfram Research, Inc., Champaign, IL, USA [34] . The program was designed to provide six modules with nine submodules, for calculating and plotting the standard combined, measurement and sampling uncertainty and the resultant confidence intervals of various diagnostic accuracy measures of a screening or diagnostic test, applied at a single point in time in non-diseased and diseased population samples. The test measures a measurand in the population samples, for varying values of their sizes, mean and standard deviation and standard measurement uncertainty of the measurand. It is assumed that the measurands and measurement uncertainty are normally distributed and that measurement uncertainty is homoscedastic. The program is freely available as a Wolfram Mathematica Notebook (.nb) (Supplementary File: Uncertainty.nb). It can be run on Wolfram Player ® or Wolfram Mathematica ® (see Appendix C). The flowchart of the program is presented in Figure 2 . The modules and submodules of the program include panels with controls which allow the interactive manipulation of various parameters, as described in detail in Supplementary File: Diagnostic Uncertainty Interface.pdf. These are the following: The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the diagnostic threshold of the test (Figure 3 ). The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the diagnostic threshold of the test (Figure 4 ). The values of the lower and upper bounds of the confidence intervals of diagnostic accuracy measure of a screening or diagnostic test, at a selected confidence level, are plotted versus the diagnostic threshold of the test ( Figure 5 ). The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the measurement uncertainty of the test ( Figure 6 ). The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the measurement uncertainty of the test (Figure 7 ). The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the diagnostic threshold of the test (Figure 3 ). Table 3 . Table 3 . The symbols are explained in Appendix A. The symbols are explained in Appendix A. The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the diagnostic threshold of the test (Figure 4 ). Table 3 . The values of the lower and upper bounds of the confidence intervals of diagnostic accuracy measure of a screening or diagnostic test, at a selected confidence level, are plotted versus the diagnostic threshold of the test ( Figure 5 ). Table 3 . Table 3 . The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the measurement uncertainty of the test (Figure 7 ). Table 3 . Table 3 . The values of the lower and upper bounds of the confidence intervals of diagnostic accuracy measures of a screening or diagnostic test, at a selected confidence level, are plotted versus the measurement uncertainty of the test (Figure 8 ). Table 3 . The values of the lower and upper bounds of the confidence intervals of diagnostic accuracy measures of a screening or diagnostic test, at a selected confidence level, are plotted versus the measurement uncertainty of the test (Figure 8 ). The respective parameter settings are also shown in Table 3 . The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the total population sample size ( Figure 9 ). Table 3 . The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the total population sample size ( Figure 9 ). The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the total population sample size ( Figure 10 ). Table 3 . The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test are plotted versus the total population sample size ( Figure 10 ). Figure 9 . Plots vs. population sample size module, DAM uncertainty plots submodule screenshot. Standard combined, measurement and sampling uncertainty of diagnostic odds ratio (u(DOR)) versus total population sample size (n) curves plot, with the settings shown on the left. The respective parameter settings are also shown in Table 3 . Table 3 . The values of the lower and upper bounds of the confidence intervals of diagnostic accuracy measures of a screening or diagnostic test, at a selected confidence level, are plotted versus the total population sample size (Figure 11 ). Table 3 . The values of the lower and upper bounds of the confidence intervals of diagnostic accuracy measures of a screening or diagnostic test, at a selected confidence level, are plotted versus the total population sample size ( Figure 11 ). Table 3 . The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test, at a selected diagnostic threshold, are calculated and presented in a table (Figure 12 ). Figure 11 . Plots vs. population sample size module, DAM CI plots submodule screenshot. Confidence intervals of likelihood ratio for a positive test result (LR+) versus total population sample size (n) curves plot, with the settings shown at the left. The respective parameter settings are also shown in Table 3 . The values of the standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test, at a selected diagnostic threshold, are calculated and presented in a table (Figure 12 ). The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test, at a selected diagnostic threshold, are calculated and presented in a table (Figure 13 ). Table 3 . The values of the relative standard combined, measurement and sampling uncertainties of diagnostic accuracy measures of a screening or diagnostic test, at a selected diagnostic threshold, are calculated and presented in a table (Figure 13 ). Table 3 . The respective parameter settings are also shown in Table 3 . The point estimations and the lower and upper bounds of the confidence intervals of diagnostic accuracy measures of a screening or diagnostic, at a selected confidence level and diagnostic threshold, are calculated and presented in a table (Figure 14) . Table 3 . The point estimations and the lower and upper bounds of the confidence intervals of diagnostic accuracy measures of a screening or diagnostic, at a selected confidence level and diagnostic threshold, are calculated and presented in a table (Figure 14 ). Table 3 . The program was applied to a bimodal distribution of log-transformed blood glucose measurements in samples of non-diabetic and diabetic populations. The data were derived from a national health survey conducted in Malaysia in 1996 [35] . A glucose tolerance test (OGTT) was performed on 2667 Malay adults, aged 40-49 years. The respective sizes of the samples of the diseased and non-diseased populations were 179 and 2488. Glucose was measured with reflectance photometry, after the ingestion of 75 g glucose monohydrate. It was assumed that the measurement coefficient of variation and bias were equal to 4% and 2%, respectively. The log-transformed measurands of each population were normally distributed, as shown in Figure 1 . The standardized log-transformed measurand means and standard deviations of the samples of the diseased and non-diseased populations, the standard measurement uncertainty and the diagnostic threshold were expressed in units equal to the standard deviation of the log-transformed measurand of the sample of the non-diseased population. The standardized log-transformed standard measurement uncertainty 0.046 of the test corresponds to coefficient of variation equal to 2%. The standardized log-transformed American Diabetes Association (ADA) diagnostic threshold for diabetes of the 2-h postprandial glucose during OGTT is equal to 2.26 [36] . The results of the illustrative example are presented: 1. In the plots of Figures 3-11 and 15-21. In the chart of Figure 22 3. In the tables of Figures 12-14 . The parameter settings of Figures 3-14 are presented in Table 3 and of Figures 15-22 in Table 4 . Figures 15-21 present the standard combined, measurement and sampling uncertainty and the resultant confidence intervals of sensitivity, specificity, positive and negative predictive value versus diagnostic threshold, measurement uncertainty and total population sample size. Table 3 . The program was applied to a bimodal distribution of log-transformed blood glucose measurements in samples of non-diabetic and diabetic populations. The data were derived from a national health survey conducted in Malaysia in 1996 [35] . A glucose tolerance test (OGTT) was performed on 2667 Malay adults, aged 40-49 years. The respective sizes of the samples of the diseased and non-diseased populations were 179 and 2488. Glucose was measured with reflectance photometry, after the ingestion of 75 g glucose monohydrate. It was assumed that the measurement coefficient of variation and bias were equal to 4% and 2%, respectively. The log-transformed measurands of each population were normally distributed, as shown in Figure 1 . The standardized log-transformed measurand means and standard deviations of the samples of the diseased and non-diseased populations, the standard measurement uncertainty and the diagnostic threshold were expressed in units equal to the standard deviation of the log-transformed measurand of the sample of the non-diseased population. The standardized log-transformed standard measurement uncertainty 0.046 of the test corresponds to coefficient of variation equal to 2%. The standardized log-transformed American Diabetes Association (ADA) diagnostic threshold for diabetes of the 2-h postprandial glucose during OGTT is equal to 2.26 [36] . The results of the illustrative example are presented: 1. In the plots of Figures 3-11 and 15-21. In the chart of Figure 22 3. In the tables of Figures 12-14. Diagnostics 2021, 11 , 406 21 of 40 Figure 15 . DAM standard uncertainties versus diagnostic threshold plots. Plots of standard combined, measurement and sampling uncertainties of (a) sensitivity (u(Se)), (b) specificity (u(Sp)), (c) positive predictive value (u(PPV)) and (d) negative predictive value (u(NPV)) versus diagnostic threshold (d) curves, with the respective parameter settings in Table 4 . Table 4 . Table 3 and of Table 4 . Figures 15-21 present the standard combined, measurement and sampling uncertainty and the resultant confidence intervals of sensitivity, specificity, positive and negative predictive value versus diagnostic threshold, measurement uncertainty and total population sample size. The combined uncertainty and the resultant confidence intervals increase with measurement uncertainty (Figures 6-8, 18 and 19 ) and decrease with total population sample size (Figures 9-11, 20 and 21 ). In the illustrative example, combined uncertainty u c (x)has (see Figures 13 and 22 ): Little effect ((u c (x)/x) < 0.5%) on specificity, overall diagnostic accuracy and negative predictive value, 2. Intermediate effect (3.5% < (u c (x)/x) < 5.5%) on sensitivity, positive predictive value, Youden's index and concordance probability, 3. Greater effect (18% < (u c (x)/x) < 39%) on diagnostic odds ratio, on likelihood ratio for a positive or negative result and Euclidean distance, in accordance with previous findings [37, 38] . In addition, measurement uncertainty is the main component of the combined uncertainty of specificity, overall diagnostic accuracy, positive predictive value, diagnostic odds ratio and likelihood ratio for a positive result. Table 4 . Table 4 . Table 4 . Table 4 . Table 4 . Table 4 . Table 4 . Table 4 . Table 4 . Table 4 . The combined uncertainty and the resultant confidence intervals increase with measurement uncertainty (Figures 6-8, 18 and 19 ) and decrease with total population sample size (Figures 9-11, 20 and 21 ). In the illustrative example, combined uncertainty has (see Figures 13 and 22 ): Little effect (( ( )/ ) < 0.5%) on specificity, overall diagnostic accuracy and negative predictive value, 2. Intermediate effect (3.5% < ( ( )/ ) < 5.5%) on sensitivity, positive predictive value, Youden's index and concordance probability, 3. Greater effect (18% < ( ( )/ ) < 39%) on diagnostic odds ratio, on likelihood ratio for a positive or negative result and Euclidean distance, in accordance with previous findings [37, 38] . In addition, measurement uncertainty is the main component of the combined uncertainty of specificity, overall diagnostic accuracy, positive predictive value, diagnostic odds ratio and likelihood ratio for a positive result. Table 4 . The program Diagnostic Uncertainty explores the combined, measurement and sampling uncertainty of diagnostic accuracy measures of a screening or diagnostic test (Figures 3, 4 , 6, 7 and 9-13) and the resultant confidence intervals (Figures 5, 8, 11 and 14) . Combined uncertainty and the resultant confidence intervals depend on the diagnostic threshold (Figures 3-5 and 15-17) , on measurement uncertainty (Figures 6-8, 18 and 19 ) and on population parameters, including the total population sample size (Figures 9-11, 20 and 21) . The complexity of the calculations of the confidence intervals of the diagnostic accuracy measures is considerable. In antithesis of the complexity of the calculations, the program simplifies its exploration with a user-friendly interface. Furthermore, it provides calculators for the calculation of the components of uncertainty of diagnostic accuracy measures and the resultant confidence intervals (Figures 12-14) . As demonstrated by the illustrative example described above, in this instance uncertainty has relatively little effect on specificity, overall diagnostic accuracy and negative predictive value. It affects more sensitivity, positive predictive value, Youden's index and concordance probability, while it has a considerable impact on diagnostic odds ratio, likelihood ratio for a positive or negative result and Euclidean distance ( Figure 22 ). However, further research is needed to explore the uncertainty of diagnostic accuracy measures with different clinically-and laboratory-relevant parameter settings. Limitations of this program, that could be improved by further research, are the following: (1) The assumptions used for the calculations: a. The existence of a "gold standard" diagnostic method. If a "gold standard" does not exist, there are alternative approaches for the estimation of diagnostic accuracy measures [39] . b. The normality of either the measurements or their applicable transforms [23, 24, 40, 41] , however, this is usually valid. There is related literature on the distribution of measurements of diagnostic tests, in the context of reference intervals and diagnostic thresholds or clinical decision limits [42] [43] [44] [45] [46] . c. The bimodality of the measurands, that is generally accepted, although unimodal distributions could be considered [47, 48] . d. The simple random sampling. e. The measurement uncertainty homoscedasticity in the diagnostic thresholds range. Nevertheless, if measurement uncertainty is heteroscedastic, thus skewing the measurements distribution, appropriate transformations may restore homoscedasticity [49] . If the above assumptions are not valid, there are other components of uncertainty which are not calculated by this program. (2) The first order Taylor series approximations for the uncertainty propagation calculations [28, 30] . Higher order approximations may improve the accuracy. (3) The uncertainty of prevalence rate approximation by the Agresti-Coull adjusted Waldo interval [25] , although there are more exact methods [50] . However, addressing these limitations, would increase exponentially the computational complexity. The program presented in this work complements our previously published software [11] , which explores the effects of measurement uncertainty on diagnostic accuracy measures applied to populations. This program calculates the standard and expanded combined, measurement and sampling uncertainty and the resultant confidence intervals of diagnostic accuracy measures of diagnostic tests, applied to samples of populations, providing 99 different types of plots and three different types of comprehensive tables (Figure 2 ), many of which are novel. To the best of our knowledge, no software, including all major general or medical statistical and uncertainty related software packages (Matlab ® , NCSS ® , R, SAS ® , SPSS ® , Stata ® , MedCalc ® , NIST Uncertainty Machine, UQLab, metRology), provides this range of plots and tables without advanced programming. The presented program Diagnostic Uncertainty calculates the combined, measurement and sampling uncertainty of diagnostic accuracy measures and the resultant confidence intervals and can be used as a flexible, user-friendly, interactive educational or research tool in medical decision-making. The data presented in this study are available in [35] . The authors declare no conflict of interest. where: Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models Measures of Diagnostic Accuracy: Basic Definitions Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges Diagnosis of SARS-CoV-2 infection and COVID-19: Accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers. Cochrane Database Syst Diagnostics 2021 The estimation of diagnostic accuracy of tests for COVID-19: A scoping review Diagnostic accuracy of serological tests for covid-19: Systematic review and meta-analysis Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes Uncertainty in Measurement and Total Error: Tools for Coping with Diagnostic Uncertainty Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results A Software Tool for Exploring the Relation between Diagnostic Accuracy and Measurement Uncertainty Network meta-analysis of diagnostic test accuracy studies identifies and ranks the optimal diagnostic tests and thresholds for health care policy and decision-making Supplements to a recent proposal for permissible uncertainty of measurements in laboratory medicine Sample size estimation in diagnostic test studies of biomedical informatics Interpreting diagnostic test accuracy studies Uncertainty Modeling and Analysis in Engineering and the Sciences Expression of Measurement Uncertainty in Laboratory Medicine, Approved Guideline Total error vs. measurement uncertainty: Revolution or evolution? Eurachem/EUROLAB/ CITAC/Nordtest/AMC Guide Simple Random Sampling Comparing Two Diagnostic Tests against the Same "Gold Standard" in the Same Sample A generalised Box-Cox transformation for the parametric estimation of clinical reference intervals The box-cox transformation: Review and extensions Operational definitions of uncertainty Basics of estimating measurement uncertainty Approximate is Better than "Exact" for Interval Estimation of Binomial Proportions Evaluation of Measurement Data-Guide to the Expression of Uncertainty in Measurement Uncertainty of Measurement: A Review of the Rules for Calculating Uncertainty Components through Functional Relationships Taylor-Series and Monte-Carlo-method uncertainty estimation of the width of a probability distribution based on varying bias and random error The Generalization of 'Student's' Problem when Several Different Population Variances are Involved An approximate distribution of estimates of variance components An Elementary Introduction to the Wolfram Language Bimodality in blood glucose distribution: Is it universal? Diabetes Care Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019 Influence of imprecision on ROC curve analysis for cardiac markers Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves, Approved Guideline Estimating diagnostic accuracy without a gold standard: A continued controversy The Box-Cox Transformation Technique: A Review An Analysis of Transformations Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits Reference interval computation: Which method (not) to choose? Application of the stockholm hierarchy to defining the quality of reference intervals and clinical decision limits A systematic review of statistical methods used in constructing pediatric reference intervals Distinguishing reference intervals and clinical decision limits-A review by the IFCC Committee on Reference Intervals and Decision Limits Principles and Practice of Screening for Disease 2.3 Clinical test evaluation. Unimodal and bimodal approaches. Scand Why do we need the uncertainty factor? Interval Estimation for a Binomial Proportion where:where: where: